[Antioxidant effect of wobenzym applied for patients with chronic glomerulonephritis].
There is formation of free radicals in mesangial cells in patients with chronic glomerulonephritis which increases destruction of renal tissue and enable autoimmune inflammation. The unbalance between activity of oxidizing and antioxidazing starts developing. It accelerates the progression of the disease. The article presents the assessment of influence of enzyme medication Wobenzym on main indices of oxidizing and antioxidazing systems. It was established the presence of antioxidant effect in Wobenzym medication. The use of this medication in combination with other drugs and without them enables restoration of the disturbed balance.
I V
IV
Mukhin
D000293:Adolescent; D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004338:Drug Combinations; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006867:Hydrolases / Q000008:administration & dosage / Q000627:therapeutic use*; D015227:Lipid Peroxidation / Q000187:drug effects; D008054:Lipid Peroxides / Q000097:blood; D008297:Male; D008875:Middle Aged; D012431:Rutin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000975:Antioxidants; D004338:Drug Combinations; D008054:Lipid Peroxides; D012431:Rutin; C023295:Wobenzym; D006867:Hydrolases